Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.2 |
mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.058 | 0.2 |
mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.2 |
mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.2 |
mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.082 | 0.2 |
mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.2 |
mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |
mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.2 |